Eagle’s Eye View: M-TEER Improves MR and LV Dysfunction
In this week’s View, Dr. Eagle evaluates how sacubitril/valsartan promotes cardiac remodeling, but not functional capacity, in nonobstructive hypertrophic cardiomyopathy. Next, he examines the prognostic value of stress perfusion cardiac magnetic resonance in patients with suspected coronary artery disease. Finally, Dr. Eagle explores a study on mitral transcatheter edge-to-edge repair (M-TEER) and its effectiveness for treatment of patients with ventricular functional mitral regurgitation (MR) and very severe left ventricular (LV) dysfunction.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Valvular Heart Disease, Atherosclerotic Disease (CAD/PAD), Acute Heart Failure, Echocardiography/Ultrasound, Nuclear Imaging, Mitral Regurgitation, Acute Coronary Syndromes
Keywords: EaglesEyeView, Ventricular Dysfunction, Left, Mitral Valve Insufficiency, Magnetic Resonance Spectroscopy, Coronary Artery Disease, Perfusion Imaging, Vasodilation, Prognosis, Ischemia, Ventricular Remodeling, Hypertrophic Cardiomyopathy, Heart Failure, Echocardiography
